Background This systematic review provides updated insights, from the published literature
in the past 5 years, based on the 2017 European Association of Neuro-Oncology (EANO) …

A cancer diagnosis is life altering and frequently associated with both acute and long-lasting
psychosocial and behavioral distress for patients. The impact of a diffuse glioma diagnosis …

Importance Every third to sixth patient with medical diseases receives antidepressants, but
regulatory trials typically exclude comorbid medical diseases. Meta-analyses of …

Background While patients with diffuse low-grade glioma (LGG) often survive for years, there
is a risk of tumor progression which may impact patients' long-term health-related quality of …

Glioma patients carry the burden of having both a progressive neurological disease and
cancer, and may face a variety of symptoms, including depression and anxiety. These …

In this study, we investigated a mathematical model for chemoimmunotherapy (a
combination of chemotherapy and immunotherapy) for brain cancer. In most cases, the …

Abstract Purpose of Review While the benefits of palliative care for patients with cancer are
well established, palliative care in neuro-oncology is still in its early stages. However, in …

Depressive symptoms are common among patients with glioblastoma, but patients are often
not treated with antidepressants. There is only limited evidence on the association of …

Abstract Purpose of Review High-grade gliomas (HGG) are rare brain tumors that cause
disproportionate suffering and mortality. Palliative care, whose aim is to relieve the …

Patients with brain tumors suffer from intense psychosocial distress. Although the
prevalence of depressive symptoms in patients with brain tumors is high, the …